Stuart Noble
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Epidemiology 13
-
- HIV/AIDS drug development and treatment 9
- Co-authors
- Karen L. Goa (14 shared papers)Diana Faulds (5 shared papers)Julie Adkins (3 shared papers)Caroline M. Spencer (5 shared papers)Gillian M. Keating (1 shared paper)Paul Benfield (4 shared papers)Caroline M. Perry (3 shared papers)Greg L. Plosker (5 shared papers)
- Journals
- Drugs (45 papers)CNS Drugs (10 papers)BioDrugs (6 papers)Drugs & Aging (5 papers)Pediatric Drugs (5 papers)
- Partner nations
- New ZealandUnited StatesUnited Kingdom
In The Last Decade
Stuart Noble
90 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 159
- Virology 343
- Infectious Diseases 773
- Pharmaceutical Science 205
- Transplantation 75
- Internal Medicine 84
Countries citing papers authored by Stuart Noble
This map shows the geographic impact of Stuart Noble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Noble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Noble more than expected).
Fields of papers citing papers by Stuart Noble
This network shows the impact of papers produced by Stuart Noble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Noble. The network helps show where Stuart Noble may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart Noble, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 235 | |
| 2 | 1997 | 234 | |
| 3 | 2003 | 201 | |
| 4 | 1995 | 156 | |
| 5 | 1998 | 154 | |
| 6 | 1996 | 147 | |
| 7 | 2004 | 141 | |
| 8 | 1996 | 139 | |
| 9 | 2006 | 136 | |
| 10 | 1998 | 131 | |
| 11 | 1998 | 124 | |
| 12 | 2003 | 104 | |
| 13 | 1997 | 101 | |
| 14 | 1998 | 98 | |
| 15 | 1999 | 97 | |
| 16 | 1998 | 93 | |
| 17 | 1995 | 86 | |
| 18 | 1996 | 80 | |
| 19 | 1999 | 77 | |
| 20 | 1999 | 77 |
About Stuart Noble
Stuart Noble is a scholar working on Epidemiology, Infectious Diseases, Pharmacology, Cardiology and Cardiovascular Medicine and Oncology, having authored 90 papers that have together received 4.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (6 papers), Asthma and respiratory diseases (5 papers), Treatment of Major Depression (4 papers), Cardiovascular Syncope and Autonomic Disorders (3 papers), Immunotherapy and Immune Responses (3 papers), Acne and Rosacea Treatments and Effects (3 papers) and Skin Protection and Aging (3 papers). The work is most often cited by research in Virology (343 citations), Infectious Diseases (773 citations), Pharmaceutical Science (205 citations), Transplantation (75 citations) and Internal Medicine (84 citations). Stuart Noble has collaborated with scholars based in New Zealand, United States and United Kingdom. Frequent co-authors include Karen L. Goa, Diana Faulds, Julie Adkins, Caroline M. Spencer, Gillian M. Keating, Paul Benfield, Caroline M. Perry, Greg L. Plosker, Anthony Markham and Julia A. Balfour. Their work appears in journals such as Drugs, CNS Drugs, BioDrugs, Drugs & Aging and Pediatric Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.